You are currently viewing a new version of our website. To view the old version click .

Multitarget Ligands

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

There are several disorders that cannot be properly treated with the old “one target–one molecule” approach, due to their multifactorial character. The complexity of these diseases suggests exploiting the simultaneous modulation of more than one target, a concept known also as polypharmacology, by using compounds which are able to interact with different macromolecules involved in the disorder under investigation. Even if the success of several drugs can be due to their fortuitous interaction with multiple macromolecules, historically, the design of multitarget-directed ligands was developed to treat Alzheimer’s Disease. Later, this approach was extended to different therapeutic areas, among them cancer, inflammation, pain, and infectious diseases.

This Special Issue aims to collect research papers and short communication to provide an overview on the recent advances in the design, synthesis, and biological evaluation of multitarget ligands for innovative therapeutic treatments.

Prof. Maria Novella Romanelli
Prof. Silvia Dei
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Drug design
  • Multitarget ligands
  • Dual modulators
  • Chemical synthesis
  • Biological activity
  • Drug targets
  • Neurodegenerative diseases
  • Cancer
  • Epigenetics
  • Pain
  • Inflammation
  • Infectious diseases
  • Polypharmacology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Molecules - ISSN 1420-3049